Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lindab International AB (publ): Lindab's Interim Report for the First Quarter 2019

First quarter 2019 · Net sales increased by 8 percent to SEK 2,315 m (2,153), of which organic growth was 5 percent. · Adjusted[1)] operating profit increased by 85 percent to SEK 192[2)] m (104). Adjusted[1)] operating margin increased to 8.3 percent (4.8). · Operating profit amounted to SEK 192[2)] m (71). · Profit for the period increased to SEK 142 m (46). · Earnings per share, before and after dilution, increased to SEK 1.85 (0.60). · Cash flow from operating activities amounted to SEK 79[2)] m (42). · On January 1, 2019, Lindab implemented a new

Storebrand Livsforsikring AS: Interim report 1st quarter 2019

Storebrand Livsforsikring AS is a wholly owned subsidiary of the listed company Storebrand ASA. For information about the Storebrand Group's Q1 2019 result and Balance sheet statement, please refer to the Storebrand Group Q1 2019 interim report. Storebrand Livsforsikring AS Group's interim report for Q1 2019 is attached. This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

Apetit Plc’s Business Review 1 January – 31 March 2019: Apetit’s operational EBIT improved thanks to Food Solutions; poor harvest still influencing Grain Trade profitability

Apetit Plc, Stock Exchange Release, 8 May 2019 at 8.30 a.m.JANUARY–MARCH 2019 IN BRIEF  January–March 2019  ·  Net sales amounted to EUR 76.4 (59.7) million  ·  Operational EBITDA was EUR 1.8 (0.6) million  ·  Operational EBIT was EUR 0.3 (-0.8) million  The information is unaudited. The figures in parentheses are the equivalent figures for the same period in 2018, and the comparison period means the corresponding period in the previous year, unless otherwise stated.  Juha Vanhainen, CEO:  “Performance at the beginning of the year continued to be held back by the

Altia Plc January-March 2019: Stable net sales development, timing of Easter and high raw material costs impacted profitability

Altia Plc Stock Exchange Release 8 May at 8:30 am EET Altia Plc Business Review January-March 2019: Stable net sales development, timing of Easter and high raw material costs impacted profitability This release is a summary of Altia Plc's Business Review January-March 2019. The complete report is attached to this release and is also available on the company website at www.altiagroup.com/investors. January–March 2019 compared to January–March 2018 · Reported net sales were EUR 73.8 (73.5) million · In constant currencies, net sales grew by 1.3% in comparison to previous year

Viking Line's new ship got 22 500 name suggestions

In early April, Viking Line initiated an open competition to find a name for its new cruise ship. Altogether 22 486 suggestions were received from Sweden, Finland, Åland and the rest of the world. Following the challenging work carried out by the jury, Viking Line has selected ten finalist entries and now invites the public to vote for their favourite. The voting starts today, 8 May.The year 2021 will denote the beginning of a new era of cruise experiences on the Baltic Sea as Viking Line launches its new climate-smart ship. The ship, which will sail the route between Turku, Finland and

Vietnam’s “K Hospital” uses Elekta solutions to make precision radiation medicine available to cancer patients

HANOI, May 8, 2019 – Elekta (EKTA-B.ST) announced today that Vietnam’s National Cancer Hospital, which is affiliated with the K Hospital, will soon begin treating cancer patients with advanced technology from Elekta. The K hospital has invested in a Leksell Gamma Knife® Icon™ system, Versa HD™ and Synergy Platform linear accelerators, as well as Monaco® treatment planning systems and MOSAIQ® oncology information system.According to the World Health Organization, almost 165,000 new cancer cases are diagnosed in Vietnam each year.[1]  And almost 115,000 of these people die from

Skanska divests logistics facility in Helsingborg, Sweden, for about SEK 240 M

Skanska has sold a logistics facility in Helsingborg, Sweden, for about SEK 240 M. The buyer is Logicenters. The divestment will be recorded by Skanska Commercial Property Development Nordic in the second quarter 2019. The transfer of the facility will take place during the first quarter 2020.The logistics facility comprises approximately 30,150 square meters and will have future-proof specifications and be adapted for the tenant PostNord TPL. The facility is being developed and built by Skanska Sweden. The property is located in a well-established business area in Helsingborg, close to

Storebrand ASA: Q1 Interim Result 2019 - Group result of NOK 733 million

·  Group result of NOK 733 million in the first Quarter ·  Solvency II 173% ·  Strong cost control - Storebrand presents a first Quarter result with strong cost control, growth in Unit linked savings and increased Assets under Management. The operating profit is weaker in the first Quarter compared to the first Quarter in 2018, mainly due to extraordinary strong insurance results last year, Odd Arild Grefstad, CEO of Storebrand Group, said. The operating profit in the first Quarter was NOK 531 million, from NOK 635 million in the first Quarter last year. The operating profit is

Share subscriptions based on stock option 2013B and stock option 2013C

CapMan Plc Stock Exchange Release                     8 May 2019 at 08:30 a.m. UTC+3 Share subscriptions based on stock option 2013B and stock option 2013C Between 22 January 2019 and 15 April 2019, a total of 240,775 CapMan Plc new shares have been subscribed for with the company's stock options 2013B and a total of 20,748 company’s new shares have been subscribed for with the company’s stock options 2013C. The entire subscription price of EUR 210,594.29 shall be recorded into the invested non-restricted equity fund. As a result of the subscriptions, the number of CapMan shares

Raisio plc: Interim Report 1 January - 31 March 2019

Raisio plc, Interim Report 8 May 2019 at 8:30 a.m. Finnish time RAISIO'S INTERIM REPORT 1 JANUARY - 31 MARCH 2019: RAISIO STARTED THE IMPLEMENTATION OF ITS NEW STRATEGY, NET SALES DECLINE STOPPED Financial development in brief, continuing operations · The Group’s net sales totalled EUR 49.9 (49.7) million. Comparable EBIT was EUR 5.0 (6.3) million, accounting for 10.0 (12.6) % of net sales. EBIT was EUR 5.0 (4.4) million, accounting for 10.0 (8.8) % of net sales. · As from January 2019, Raisio’s reportable segments are Healthy Food and Healthy Ingredients. · The Healthy

Apetit to update operational indicators

Apetit Plc, Stock Exchange Release, 8 May 2019 at 8:25 a.m.Apetit Plc is updating its operational indicators and in the future the company will present operational indicators without the IAS-2 Inventories -standard capitalisation of fixed costs at inventory value. Due to harvest-time production, the IAS-2 accounting practice means that most of the profit is accrued in the last two quarters of the year, which weakens the result for the first two quarters and causes seasonal variation. As a result of this change, the information made available to investors will also better match the

Double-digit growth for all strategic brands and DKK 4,234 million in revenue and DKK 1,200 million in EBIT

HIGHLIGHTS · Revenue reached DKK 4,234 million in the first quarter of 2019 representing a decline of 8% (6% in local currencies) compared to the same period last year. The decline was expected and a result of generic competition on Onfi® · Revenue of Abilify Maintena® increased 27% to DKK 462 million (24% in local currencies) · Revenue of Brintellix®/Trintellix® increased 29% to DKK 601 million (27% in local currencies) · Revenue of Northera® increased 10% to DKK 435 million (3% in local currency) · Revenue of Rexulti®/Rxulti® increased 30% to DKK 481 million (22%

HKScan Group’s Interim Report 1 January–31 March 2019: The company's loss decreased clearly – balancing finances started

HKScan Corporation             INTERIM REPORT               8 May 2019               at 8:15 EESTHKScan Group’s Interim Report 1 January–31 March 2019: The company's loss decreased clearly – balancing finances started JANUARY–MARCH 2019 IN BRIEF ·  Net sales were EUR 401.8 (411.0) million. ·  EBIT was EUR -14.7 (-18.3) million, and the EBIT margin -3.6 (-4.4) per cent. Danish asset prices were depreciated by 4,5 million after impairment testing. ·  Comparable EBIT was EUR -10.1 (-18.1) million. The corresponding EBIT margin was -2.5 (-4.4) per cent. ·  EPS was EUR -0.33 (-0.

Targovax announces completed enrollment of ONCOS-102 trial in mesothelioma

·  The trial is now fully recruited, with a total of 31 patients enrolled   ·  Data read-outs expected around New Year Oslo, Norway, 8 May 2019 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces that it has completed patient enrollment in the phase Ib/II trial of ONCOS-102 in combination with chemotherapy in unresectable malignant pleural mesothelioma (MPM).  The trial consists of a phase Ib safety lead-in part followed by a randomized, open label phase II part, assessing the

HKScan’s Board of Directors decided on new plan periods within the share-based long-term incentive scheme for key employees

HKScan Corporation             Stock Exchange Release 8.5.2019, at 8.05 (EEST)HKScan’s Board of Directors decided on new plan periods within the share-based long-term incentive scheme for key employees The Board of Directors of HKScan Corporation has approved new plan periods within the share-based long-term incentive scheme for HKScan's key employees. The long-term incentive scheme comprises a Performance Share Plan (also “PSP”) and a Restricted Share Plan (also “RSP”). HKScan announced the establishment of the share-based long-term incentive scheme with a stock exchange release on 7

BerGenBio ASA: Results for the First Quarter 2019

· Advanced leukaemia (AML/MDS): Phase II trial fully recruited and combination trial with low-intensity chemotherapy meets efficacy endpoint in hard to treat relapsed / refractory (R/R) leukaemia · Advanced lung cancer (NSCLC): Additional cohort added in trial of bemcentinib in combination with anti-PD-1 therapy KEYTRUDA® · Anti-AXL antibody, BGB149, commenced phase I safety and pharmacokinetic clinical trial.Bergen, Norway, 08 May 2019 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer

Fortum enters into partnership with Spinnova to continue building its bio-based ecosystem

Fortum and Spinnova Oy, a developer of sustainable textile fibre, have entered into a partnership to produce fibre from agro residues and woody biomass. The cooperation is another step towards Fortum’s strategy to build options for significant new businesses that improve resource efficiency and provide smart solutions for a cleaner world. Fortum is currently evaluating different biomass fractionation technologies and has identified microfibrillated cellulose (MFC) as one potential intermediate product from the cellulose fraction. Spinnova’s technology, presently in the large industrial-

Nightingale Health collaborates with National University of Singapore to realise the prevention of chronic diseases in South East Asia

Nightingale Health Ltd., the Finnish innovator of an internationally recognised blood analysis technology for studying chronic diseases today announced the first step in a major collaboration with the National University of Singapore (NUS), one of the world’s leading universities to realise the prevention of chronic diseases in South East Asia.In the first phase of the collaboration, Nightingale will provide NUS with novel biomarker data for 5,000 blood samples from the Singapore Multiethnic Cohort (MEC) collection, representing the Malay, Indian and Chinese populations in Singapore. The

RepRisk integrates Sustainability Accounting Standards Board (SASB) Framework

Investors can identify environmental, social, and governance (ESG) risks that are most material to the industries they invest inRepRisk, a global leader in data science, specializing in premium ESG and business conduct risk research, is pleased to announce the application of the SASB Materiality Map® in its risk management and compliance solutions. RepRisk is mapping its core research scope of 28 ESG issues against the 26 sustainability issues that comprise the SASB Materiality Map®. The Map identifies those sustainability issues that are likely to affect the financial condition or

Invitation to presentation of Multiconsult ASA's first quarter 2019 results

Multiconsult ASA's first quarter 2019 results will be released on Thursday 23 May at 07:00 CET. The complete report and presentation will be available at www.multiconsult-ir.com and www.newsweb.no.A presentation of the first quarter 2019 results will be held in Norwegian at 09:00 CET, followed by a conference call at 10:30 CET in English. The Norwegian presentation will be held at Hotel Continental, Stortingsgaten 24/26, Oslo.The presentation will be held by CEO Grethe Bergly and CFO Hans-Jørgen Wibstad. A live webcast from the Norwegian presentation can be accessed at www.

Magnolia Bostad and Heimstaden Bostad form JV for the development of residencies in Upplands-Bro

Magnolia Bostad and Heimstaden Bostad have formed a joint venture with the aim of jointly developing around 800 residencies in the new southern part of Bro, in Upplands-Bro municipality. The land was owned by Magnolia Bostad and is being acquired by the joint venture company.The joint venture has entered into an agreement to acquire part of Magnolia Bostad's Brogårdstaden project in the southern part of Bro, in Upplands-Bro municipality. The land has legally binding zoning planning and the buildings will consist of residential apartments in multi-dwelling buildings and small houses

There are no items matching the current filter
There are no more items matching the current filter
Back to top